ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Regulatory Tolerance Across a Full MHC Barrier Is More Robust Than Tolerance Across a Class I MHC Disparity Alone

M. Madariaga, S. Michel, G. La Muraglia II, M. O'Neil, W. Orent, V. Villani, M. Sekijima, E. Farkash, R. Colvin, J. Allan, K. Yamada, J. Madsen, D. Sachs.

Transplantation Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA.

Meeting: 2015 American Transplant Congress

Abstract number: 246

Keywords: MHC class I, MHC class II, Tolerance

Session Information

Session Name: Concurrent Session: Transplant Tolerance: Animal Models I

Session Type: Concurrent Session

Date: Monday, May 4, 2015

Session Time: 2:15pm-3:45pm

 Presentation Time: 3:15pm-3:27pm

Location: Room 121-C

Background: We previously demonstrated that tolerance of hearts and/or kidneys achieved across a class I MHC mismatch with 12 days of CyA can be abrogated by challenge with skin grafts or class I peptide immunization. In this study, we investigated whether the state of tolerance of class I antigens achieved across a full MHC mismatch is quantitatively or qualitatively different from that induced across a class I MHC mismatch alone.

Methods: Miniature swine that were tolerant of heart and/or kidney allografts long-term across class I or full MHC disparities underwent class I peptide immunization or placement of skin grafts expressing donor class I and 3rd party class II antigens. Animals tolerant of heart and kidney allografts across a full MHC mismatch underwent kidney allograftectomy to prior to skin grafting (Group 1, n=3) or heart and kidney allograftectomy prior to peptide immunization (Group 2, n=3). Animals tolerant of heart and kidney allografts across a class I MHC mismatch underwent kidney allograftectomy prior to skin grafting (Group 3, n=4). Animals tolerant of kidney allografts across a class I MHC mismatch underwent kidney allograftectomy prior to peptide immunization (Group 4, n=2).

Results: Challenge skin grafting resulted in rejection of heart allografts within 50 days in animals tolerant across a class I MHC mismatch (Group 3); in contrast, animals tolerant across a full MHC mismatch maintained long-term heart allograft survival >100 days after skin grafting (Group 1). Class I peptide immunization resulted in return of anti-donor responsiveness by CML, IgG alloantibody production, and rejection of a subsequently placed donor-matched kidney allograft in animals tolerant across a class I MHC mismatch (Group 4) but not in animals tolerant across a full MHC mismatch (Group 2).

Conclusion: Once established, the state of tolerance to class I antigens induced across a full MHC mismatch appears to be more stable than that induced across an isolated class I MHC mismatch. The addition of a class II disparity in a full MHC mismatch thus appears to lead to the generation of more robust down-regulation of class I-specific alloreactivity.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Madariaga M, Michel S, II GLaMuraglia, O'Neil M, Orent W, Villani V, Sekijima M, Farkash E, Colvin R, Allan J, Yamada K, Madsen J, Sachs D. Regulatory Tolerance Across a Full MHC Barrier Is More Robust Than Tolerance Across a Class I MHC Disparity Alone [abstract]. Am J Transplant. 2015; 15 (suppl 3). https://atcmeetingabstracts.com/abstract/regulatory-tolerance-across-a-full-mhc-barrier-is-more-robust-than-tolerance-across-a-class-i-mhc-disparity-alone/. Accessed May 17, 2025.

« Back to 2015 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences